Under Medtronic’s plan, the new unnamed company will also be publicly traded, Medtronic said. The diabetes business generated nearly $2.8 billion in sales in its most recent fiscal year, ...

Among Medtronic’s other businesses, cardiovascular revenue increased 6.6% to $3.34 billion, neuroscience revenue rose 2.9% to $2.62 billion and medical surgical revenue edged up 0.6% to $2.21 ...

(Reuters) -Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps and other wearable devices, into a stand-alone company and ...

Medtronic's revenue is equivalent to 86% of the combined sales of those three companies. "The number of Class 1 recalls in recent years is atypical for us," Medtronic's Winkels said.

Medtronic (MDT 1.54%) is not new to innovation. The medical device giant sells a broad range of cutting-edge products, such as the Hugo robotic surgery system and the world's first insulin pump ...

Trefis estimates Medtronic’s Q4 fiscal 2023 total revenues to be around $8.2 billion, reflecting a low single-digit y-o-y rise but marginally below the $8.3 billion consensus estimate.

When Geoff Martha, chairman and CEO of Medtronic, took over the medical device maker’s Restorative Therapies Group in 2015, the company faced a tough decision.

Medtronic’s adjusted third-quarter profit tops analyst estimates but its surgical-products revenue dips on temporary inventory issue Last Updated: Feb. 18, 2025 at 12:26 p.m. ET First Published ...

Net sales at Medtronic's medical surgical unit for fiscal 2023 were $8.43 billion, down 7.7% from the year earlier, as demand for ventilators cooled off from the levels seen during the COVID-19 ...

After seeing flagging sales across its segments during the past three quarters, Medtronic has begun moving forward with layoffs that will span its international businesses. With about 100,000 ...

Medical-device maker Medtronic plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a division that had struggled but recently returned to ...

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps and other wearable devices, into a stand-alone company and forecast 2026 ...